Journey Medical (DERM) Current Assets (2020 - 2026)

Journey Medical's Current Assets history runs 7 years deep, the most recent figure standing at $65.0 million for Q1 2026.

• Quarterly Current Assets rose 20.34% year-over-year to $65.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.0 million (up 20.34% YoY) and the FY2025 annual result came in at $66.9 million, up 38.8% from the prior year.
• Current Assets was $65.0 million for Q1 2026 at Journey Medical, down from $66.9 million in the prior quarter.
• Across five years, Current Assets topped out at $90.3 million in Q1 2022 and bottomed at $44.7 million in Q3 2023.
• A 5-year average of $60.1 million and a median of $56.4 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2023 — Current Assets tumbled 43.86% — and 2025, when it soared 38.8%.
• Journey Medical's Current Assets stood at $77.7 million in 2022, then retreated by 27.32% to $56.5 million in 2023, then declined by 14.66% to $48.2 million in 2024, then surged by 38.8% to $66.9 million in 2025, then dropped by 2.85% to $65.0 million in 2026.
• Business Quant data shows DERM's Current Assets at $65.0 million in Q1 2026, $66.9 million in Q4 2025, and $56.4 million in Q3 2025.